Djibouti vs Fiji: Access to anti-retroviral drugs, male
Djibouti
28.0%
in 2024
Fiji
28.0%
in 2024
Djibouti rank
133rd
Fiji rank
133rd
Access to anti-retroviral drugs, male over time
- Djibouti
- Fiji
How they compare
Djibouti currently reports 28.0% against 28.0% in Fiji, a difference of 0.0%.
The two have swapped places 6 times across 24 shared years of data; in 2000 it was Fiji ahead.
Djibouti ranks 133rd and Fiji ranks 133rd of 141 countries.
Across the 3 decades both report, Djibouti averaged higher in 1 and Fiji in 2.
Head to head by decade
| Decade | Djibouti | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.8% | 45.8% | 44.0% | Fiji |
| 2010s | 13.0% | 33.5% | 20.5% | Fiji |
| 2020s | 23.2% | 19.6% | 3.6% | Djibouti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Djibouti or Fiji?
- Djibouti, at 28.0% against 28.0% in Fiji as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Djibouti and Fiji?
- 0.0%, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and Fiji?
- 24 years are reported by both, from 2000 to 2024.
- How do Djibouti and Fiji rank globally for access to anti-retroviral drugs, male?
- Djibouti ranks 133rd and Fiji ranks 133rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.